Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Other ETFs median (248 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 24 Aug 2018 – 20 Aug 2026, limited by ICICI Prudential Nifty Next 50 ETF. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | ICICI Prudential Nifty Next 50 ETF | Nifty 50 |
|---|---|---|
| 24 Aug 2018 | ₹100.00 | ₹100.00 |
| 24 Apr 2019 | ₹92.02 | ₹101.46 |
| 23 Dec 2019 | ₹93.79 | ₹106.11 |
| 23 Aug 2020 | ₹91.86 | ₹98.39 |
| 23 Apr 2021 | ₹114.05 | ₹124.09 |
| 22 Dec 2021 | ₹138.68 | ₹146.71 |
| 22 Aug 2022 | ₹142.77 | ₹151.34 |
| 22 Apr 2023 | ₹129.76 | ₹152.50 |
| 21 Dec 2023 | ₹174.59 | ₹183.91 |
| 21 Aug 2024 | ₹252.42 | ₹214.33 |
| 21 Apr 2025 | ₹223.39 | ₹208.75 |
| 20 Dec 2025 | ₹234.98 | ₹224.68 |
| 20 Aug 2026 | ₹256.49 | ₹209.67 |
| Metric | ICICI Prudential NAV ₹78.35 Very High risk ★★★★☆ | Category median Other ETFs · 248 funds |
|---|---|---|
| +9.68% | +3.65% | |
| +20.11% | +10.51% | |
| +14.34% | +9.28% | |
| — | +11.93% | |
| +12.51% | +10.38% | |
| +15.09% | — | |
| +18.33% | +14.30% | |
| +18.35% | +13.74% | |
| — | +12.83% | |
| Risk | ||
| 18.50% | 15.45% | |
| 0.74 | 0.28 | |
| 0.99 | 0.41 | |
| -40.04% | -20.59% | |
| Nifty 50 | — | |
| +10.59% | +0.80% | |
| 1.30 | 1.00 | |
| 144.6% | 102.1% | |
| 94.6% | 96.4% | |
| 0.16% | 0.32% | |
| ₹2,463Cr | ₹137.31Cr | |
| — | — | |
| — | — | |
| — | — | |
| — | — | |
| — | — | |
| Ashwini Bharucha | — | |
| 24 Aug 2018 | — | |
| 50 | — | |
| 32.8% | — | |
| — | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.